InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: farrell90 post# 307263

Wednesday, 07/01/2020 11:50:40 AM

Wednesday, July 01, 2020 11:50:40 AM

Post# of 403624
Great post farrell90!

Message in reply to:
Brilacidin should be moving up the list. The RBL studies show very positive in vitro activity against Covid 19.

The following have all had disappointing Covid 19 studies published:
Favipirvir,Chloroquine,Acterma,Ritonavir,Remdesivir,Kevsara, Sarilumab.

Cynk-001 Has reported antiviral and anti-inflammatory properties according to the company. I could find not reports of any kind of Coronavirus in vitro studies US studies. Chinese in vitro reports seem without much factual evidence.

BDB-1 Is a monoclonal antibody against complement factor C5a a component of the inflammatory complement cascade. It is reported to decrease inflammmation. The Chinese company is reporting a trial in healthy volunteers was successful and it is to enter clinical trials in Europe.

Rintatolimod is an anti inflammatory previously studied as an AIDS drug. It is approved as a treatment for chronic fatigue in Argentina. It is set to be studied in Argentina and Japan in a Covid 19 trial.

BCG is an old TB accine which may have anti-inflammatory effects.

Ino-4800 Inovio has reported signs of immune response in its Phase 1 trial.

So Brilacidin, a therapeutic,and INO-4800, a vaccine, are the most successful therapies in the list to date.

We will have a better idea where they stand in a few months.

JMO I would be happy to have anyone post additional information on the pharmaceuticals above.

GLTA,Farrell





To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News